Ani Pharmaceuticals Inc share price logo

Ani Pharmaceuticals Inc Share Price

NASDAQ: ANIP

Small Cap

$94.75

+2.80

(+3.05%)

as on

Ani Pharmaceuticals Inc Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $90.7
    $95.94
    downward going graph

    4.27%

    Downside

    1.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $52.5
    $99.5
    downward going graph

    44.59%

    Downside

    5.01%

    Upside

    downward going graph

Ani Pharmaceuticals Inc share price movements today

Previous Close
$91.95
Open
$90.70
Volume
304.2K
Day's Low - High
$90.7 - $95.94
52 Week Low - High
$52.5 - $99.5

Ani Pharmaceuticals Inc Historical Returns

1 Month Return
-2.76 %
3 Month Return
+ 42.97 %
1 Year Return
+ 57.17 %
3 Year Return
+ 168.22 %
5 Year Return
+ 218.19 %

Ani Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Ani Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

7.3077

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.17%

PE Ratio (TTM)

54.02

Industry PE ratio

-0.32286624203821657

PEG Ratio

1.06

EBITDA

104.3M

Revenue (TTM)

747.4M

Profit Margin

-1.37%

Return On Equity TTM

179449000.00%

Ani Pharmaceuticals Inc Stock Valuation

Track how Ani Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Ani Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (8.18x)

December 31, 2020

Industry (-0.32x)

October 18, 2025

Today (54.02x)

October 18, 2025

Highest (42.03x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 54.02x

Ani Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ani Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.1B218.19%54.02-1.37%
BUY$19.6BNA16.9140.36%
BUY$41.0BNA20.4413.81%
BUY$13.9B36.66%41.4513.88%
BUY$63.8B-11.92%24.827.83%

Stock Returns calculator for Ani Pharmaceuticals Inc Stock including INR - Dollar returns

The Ani Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ani Pharmaceuticals Inc investment value today

Current value as on today

₹1,61,899

Returns

₹61,899

(+61.9%)

Returns from Ani Pharmaceuticals Inc Stock

₹57,105 (+57.1%)

Dollar Returns*

₹4,794 (+4.79%)

Analyst Recommendation on Ani Pharmaceuticals Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ani Pharmaceuticals Inc. Average target price of $107

Ani Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Ani Pharmaceuticals Inc.

What analysts predicted

11.45%UPSIDE

Target Price

$107

Current Price

$94.75

Analyzed by

11 Analysts

Target

$107.00

Ani Pharmaceuticals Inc target price $107, a slight upside of 11.45% compared to current price of $94.75. According to 11 analysts rating.

Ani Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Ani Pharmaceuticals Inc Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Ani Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
106
116
131
131
137
138
148
190
197
211
Gross Profit
69
74
83
63
73
65
85
110
124
113
Operating Income
9
12
17
6
15
5
-20
-4
26
13
EBITDA
26
26
30
23
29
23
-13
14
50
42
Interest Expense
7
7
6
5
4
4
2
6
8
8
Depreciation
14
14
15
15
14
14
15
22
22
23
Income Before Tax
2
5
11
0
25
-2
-31
-13
19
10
Income Tax Expense
0
0
1
0
7
-
-7
-3
4
1
Net Income
1
6
9
1
18
-2
-24
-10
15
7
Net Profit Margin
1.35%
5.36%
7.54%
0.88%
13.25%
-1.66%
-16.29%
-5.39%
7.95%
3.66%

Ani Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
76
128
176
201
206
208
216
316
486
614
Gross Profit
63
79
97
128
143
121
115
177
305
364
Operating Income
32
20
28
35
16
-16
-39
-35
46
0
EBITDA
39
56
57
69
60
24
-1
33
106
79
Interest Expense
11
11
12
14
12
9
11
28
26
17
Depreciation
-
-
27
33
44
44
47
56
60
67
Income Before Tax
21
8
16
20
3
-25
-56
-62
19
-22
Income Tax Expense
6
4
17
4
-2
-3
-13
-14
1
-3
Net Income
15
3
-1
15
6
-22
-42
-47
18
-18
Net Profit Margin
20.14%
3.06%
-0.61%
7.69%
2.95%
-10.82%
-19.71%
-15.14%
3.86%
-3.01%

Ani Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
6
9
1
18
-2
-22
-10
15
8
Operating Cash Flow
20
32
44
18
17
12
15
34
75
Investing Cash Flow
-6
-4
-4
8
-4
-398
-10
-19
-6
Financing Cash Flow
80
3
-11
-19
-1
291
-4
-9
-1
Change in Cash
93
31
28
7
11
-95
0
4
67

Ani Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
3
-1
15
6
-22
-42
-47
18
-18
Operating Cash Flow
27
39
67
45
15
3
-31
118
64
Investing Cash Flow
-154
-107
-27
-27
-68
-105
-15
-18
-404
Financing Cash Flow
0
72
-27
1
-1
194
-5
67
264
Change in Cash
-127
3
11
19
-54
92
-52
167
-76

Global Institutional Holdings in Ani Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
11.9%
Vanguard Group Inc
5.89%
Millennium Management LLC
4.63%
Global Alpha Capital Management Ltd.
3.97%
State Street Corp
3.3%

Ani Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 16 October

    Thu, 06:19 PM

    -

    ANI Pharmaceuticals expected to report Q3 2025 results soon, with EPS projected to surge 29.9% year-over-year.

Insights on Ani Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ANIP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 131.65M → 211.37M (in $), with an average increase of 7.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ANIP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ANIP stock has moved up by 43.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.68M → 7.73M (in $), with an average decrease of 50.7% per quarter

About Ani Pharmaceuticals Inc

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
OrganisationAni Pharmaceuticals Inc
Headquarters210 Main Street West, Baudette, MN, United States, 56623
IndustryHealth Technology
CEOMr. Nikhil Lalwani
E-voting on sharesClick here to vote

Key Management of Ani Pharmaceuticals Inc

Name

Title

Ms. Krista L. Davis

Senior VP & Chief Human Resources Officer

Mr. Nikhil Lalwani

President, CEO & Director

Mr. Stephen P. Carey

Senior VP of Finance & CFO

Mr. Chad Gassert

Senior Vice President of Corporate Development & Strategy

Mr. Muthusamy Shanmugam MS R.Ph.

Head of R&D, COO of New Jersey Operations & Director

Ms. Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Dr. Mary Pao M.D., Ph.D.

Chief Medical Officer

Ms. Meredith W. Cook J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Christopher K. Mutz

Senior VP & Head of Rare Disease

Mr. Ori Gutwerg

Senior Vice President of Generics

FAQs

What is Ani Pharmaceuticals Inc share price today?

Ani Pharmaceuticals Inc share price today is $94.75 as on at the close of the market. Ani Pharmaceuticals Inc share today touched a day high of $95.94 and a low of $90.7.

What is the 52 week high and 52 week low for Ani Pharmaceuticals Inc share?

Ani Pharmaceuticals Inc share touched a 52 week high of $99.5 on and a 52 week low of $52.5 on . Ani Pharmaceuticals Inc stock price today i.e. is closed at $94.75,which is 4.77% down from its 52 week high and 80.48% up from its 52 week low.

What is Ani Pharmaceuticals Inc's market capitalisation today?

Ani Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Ani Pharmaceuticals Inc Stock (ANIP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ani Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ani Pharmaceuticals Inc Shares that will get you 0.0158 shares as per Ani Pharmaceuticals Inc share price of $94.75 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ani Pharmaceuticals Inc Stock (ANIP) from India?

Indian investors can start investing in Ani Pharmaceuticals Inc (ANIP) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Ani Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ani Pharmaceuticals Inc share’s latest price of $94.75 as on October 18, 2025 at 1:29 am IST, you will get 0.1055 shares of Ani Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Ani Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Ani Pharmaceuticals Inc stock has given 218.19% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?